Latest Post

IAS 2019: While dispelling concerns of DPM HIV risk, ECHO study yields data on STIs, PrEP interest, pregnancy rates

MEXICO CITY – Women using Depo Provera as a long acting, injectable hormonal contraceptive showed lower rates of sexually transmitted infection that include chlamydia and gonorrhea, during a study undertook with the primary aim of assessing whether the drug raised risks of HIV infection. This is one in several findings released Monday from the Evaluation of […]

More »

Recent Posts

IAS 2019: Data shows indigenous, nonbinary populations among those missed by HIV epidemic ending efforts

MEXICO CITY – Indigenous communities in the Americas are largely being left out of efforts to achieve UNAIDS’ global HIV elimination targets of 90 percent of people knowing their HIV status by 2020, 90 percent of people diagnosed with HIV accessing lifesaving antiretroviral therapy, and 90 percent of people on treatment achieving viral suppression, indigenous leaders […]

More »

IAS 2019: With new data, WHO updates DTG guidelines including women in strong, preferred recommendation

MEXICO CITY – Responding to expanded data gathered in Botswana and Brazil, and to input from communities of women living with HIV, the World Health Organization announced updated guidelines for the use of dolutegravir, restoring the agency’s recommendation that the antiretroviral medicine with fewer side effects, lower resistance, and quicker viral suppression than alternatives is […]

More »
More Recent Posts »

Live Blog Archive


Click above for a video on our Congressional study tour to Africa, and click here to read more.


Amid declining donor dollars, resource gaps threaten HIV goals, reports say

Progress seen in recent years against the HIV pandemic, including in rising numbers of people diagnosed and treated accompanied by dropping rates of incidence and death, […]


Global Health Security 2019: Unmet needs increase worldwide threat of drug-resistant TB

SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after […]

Research & Development

STREAM Trial: Nine-month regimen for drug-resistant tuberculosis brings “promising cure rates”

A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]


With data on largest AFM outbreak yet, CDC urges readiness to recognize, report cases

With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]